RNA, Technology and IP Attorneys

Ranjan Narula, Abhishek Nangia, and Shakti Priyan Nair of RNA, Technology and IP Attorneys outline various progressive and business-friendly changes under the Jan Vishwas (Amendment of Provisions) Act, 2023, but identify several potential issues

Ranjan Narula and Suvarna Pandey of RNA, Technology and IP Attorneys consider the implications of a High Court of Delhi ruling concerning a patented compound used to treat non-small cell lung cancer

A decision by the High Court of Delhi has confirmed that the denigration of another brand in comparative advertising crosses the line, say Ranjan Narula and Daleep Kumar of RNA, Technology and IP Attorneys

Ranjan Narula and Suvarna Pandey of RNA Technology and IP Attorneys welcome the introduction of India’s new patent rules and highlight the key changes

Ranjan Narula and Mohandas Konnanath of RNA Technology and IP Attorneys analyse a ruling by the High Court of Delhi concerning the use of marks for facial cleansers

Ranjan Narula and Suvarna Pandey of RNA Technology and IP Attorneys discuss a case that centred around the submission of data in support of an enhanced therapeutic efficacy claim for a compound